BridgeMD
New treatment option for Aging
Official title Study of the Evolution of the Expression of the LAMP-2 Protein During the Advance in Age
ClinicalTrials.gov ID: NCT06357923
What this study is testing
- What it's testing
- Recruitment on the RAV pole in consultation or day hospital. Competitive recruitment of subjects \> 60 years of age respecting a male/female ratio = 1.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 99
You may be able to join if
- Men and women over 60 years of age.
You likely can't join if
- Inability to Understand Consent,
- Non-Security Beneficiaries
- social, people protected by law, people deprived of liberty,
- history of breast cancer,
- brain tumor,
- melanoma,
See the full eligibility criteria
- Men and women over 60 years of age.
- Inability to Understand Consent,
- Non-Security Beneficiaries
- social, people protected by law, people deprived of liberty,
- history of breast cancer,
- brain tumor,
- melanoma,
- colon cancer,
- lung cancer,
- prostate cancer,
- lymphoma,
- myeloma,
- syndrome myelodysplastic/myeloproliferative,
- leukemia,
- history of radiation therapy.
The study team makes the final eligibility decision.
Where it's taking place
- Nice, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nice, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.